Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
FDA accepts Kowa's application for glaucoma eye drops K-911
The FDA has accepted for review the marketing application for Kowa's K-911, a once-daily, nitric oxide–releasing bimatoprost to lower intraocular pressure, and has set its decision date for April 30, 2027. The filing is supported by two Phase 3 studies (Mont Blanc, Denali) versus latanoprost. Kowa plans, subject to approval, to launch in the U.S. in the second half of 2027; Nicox remains the discoverer and trial conductor. » Altro su de.investing.com
Ardelyx raises revenue forecast and emphasizes growth plans despite regulatory risks
Ardelyx raised the revenue forecast for IBSRELA to $250–260 million and sees peak revenue potential for Exposa of $750 million, while the company expands its sales and marketing efforts. Management says breakeven is within reach, is exploring international partnerships and portfolio expansions, but acknowledges an upcoming CMS legal case could affect business progress. Kowa Kirin provides API revenue from a partnership; a full transcript of the conference presentation was released. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | maggio 2026 | |
|---|---|---|
| Ricavi | 9,69 Mln | 10,13% |
| Utile lordo | 4,41 Mln | 6,87% |
| Utile netto | 1,05 Mln | 46,27% |
| EBITDA | 1,89 Mln | 18,57% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 19,9 Mln € |
Numero di azioni | 4,16 Mln |
Massimo/minimo a 52 settimane | 5,02 € - 4,43 € |
Rendimento da dividendo | 1,59% |
Dividendi TTM | 0,07 € |
Beta | 0,35 |
Rapporto P/E | 7,02 |
Rapporto PEG | 5,85 |
Rapporto P/B | 0,98 |
Rapporto P/S | 0,55 |
Profilo aziendale
Kowa Co.,Ltd. beschäftigt sich mit der Herstellung und dem Verkauf von Pflegeprodukten und Sozialeinrichtungen in Japan. Das Unternehmen bietet silberne Autos, Gehwagen und Gehstöcke für die Gehhilfe an. Es ist auch in der Vermietung von Sozialeinrichtungen und im Tagespflegegeschäft tätig. Das Unternehmen vertreibt seine Pflegeprodukte über den Versandhandel und online. Das Unternehmen wurde 1965 gegründet und hat seinen Hauptsitz in Osaka, Japan.
| Nome | KOWA COMPANY LIMITED Aktie |
| CEO | Hiroshi Yashiro |
| Sede centrale | Osaka,
os Giappone |
| Sito web | |
| Quotazione in borsa | 29/11/2017 |
| Dipendenti | 211 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
Frankfurt | 49N.F |
Scopri gli asset
Gli azionisti di KOWA COMPANY LIMITED Aktie investono anche nei seguenti asset
